Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Will a Mindfulness-Based Treatment for Depression Increase Recovery Rates?

2.

Less Mental Decline With Darolutamide vs Enzalutamide in PC

3.

FDA Approves Subcutaneous Isatuximab for MM Indications

4.

More Positive Survival Data in Lung Cancer With Perioperative Therapy

5.

Finding a clue to the origin of treatment-resistant leukemia in kids


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot